Abstract

When using biosensors, analyte biomolecules of several different concentrations are percolated over a chip with immobilized ligand molecules that form complexes with analytes. However, in many cases of biological interest, e.g., in antibody interactions, complex formation steady-state is not reached. The data measured are so-called sensorgram, one for each analyte concentration, with total complex concentration vs time. Here we present a new four-step strategy for more reliable processing of this complex kinetic binding data and compare it with the standard global fitting procedure. In our strategy, we first calculate a dissociation graph to reveal if there are any heterogeneous interactions. Thereafter, a new numerical algorithm, AIDA, is used to get the number of different complex formation reactions for each analyte concentration level. This information is then used to estimate the corresponding complex formation rate constants by fitting to the measured sensorgram one by one. Finally, all estimated rate constants are plotted and clustered, where each cluster represents a complex formation. Synthetic and experimental data obtained from three different QCM biosensor experimental systems having fast (close to steady-state), moderate, and slow kinetics (far from steady-state) were evaluated using the four-step strategy and standard global fitting. The new strategy allowed us to more reliably estimate the number of different complex formations, especially for cases of complex and slow dissociation kinetics. Moreover, the new strategy proved to be more robust as it enables one to handle system drift, i.e., data from biosensor chips that deteriorate over time.

Highlights

  • Biological medicines, such as peptides, proteins, mRNA, oligonucleotides, vaccines, and plasmids,[1−4] are a strongly growing area of importance for the pharmaceutical industry.[5,6] Reliable analysis of biomolecular interactions is crucial in order to fulfill modern drug quality assurance criteria, both for traditional small API molecules[7] and for next-generation biological drugs

  • We suggest the new four-step strategy for the reliable estimation of the rate constants from sensorgram data

  • The four-step strategy is based on our new fast Adaptive Interaction Distribution Algorithm (AIDA)

Read more

Summary

Introduction

Biological medicines, such as peptides, proteins, mRNA, oligonucleotides, vaccines, and plasmids,[1−4] are a strongly growing area of importance for the pharmaceutical industry.[5,6] Reliable analysis of biomolecular interactions is crucial in order to fulfill modern drug quality assurance criteria, both for traditional small API molecules[7] and for next-generation biological drugs. If the complex formation reactions are sufficiently fast to reach steady-state, one way to accurately estimate the number of interactions is to use a three-step approach based on an algorithm called Adsorption Energy Distribution (AED) calculations.[17,18] This approach has been used for adsorption studies in several publications, both for SPR19 and QCM20,21 biosensors. The new strategy will be compared to the conventional method, i.e., to simultaneously fit a one or twosite kinetic model to all sensorgrams, so-called global fitting This four-step strategy can be applied to the clarification of interactions between biomolecules and cell surfaces, present in a very complex and biologically relevant environment where a more complex fitting model is often needed

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call